Showing results (1061-1070 of 1,213) with videos related to

Sort By:
Pageof 122
Transplantation Proceedings|April 29, 2014
Prevalence and treatment of new-onset diabetes mellitus after liver transplantation in Korean children: a single-center studyJ M Cho, S H Oh, K M Kim, et al.
Journal of Korean Medical Science|April 6, 2001
Spontaneous acute tumor lysis syndrome with advanced gastric cancerI S Woo, J S Kim, M J Park, et al.
Transplantation Proceedings|December 21, 2010
Intractable recurrent hepatitis A virus infection requiring repeated liver transplantation: a case reportG C Park, S Hwang, Y D Yu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2013
Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)H R Kim, K H Jung, S-A Im, et al.
Transplantation Proceedings|March 14, 2012
Standardization of modified right lobe grafts to minimize vascular outflow complications for adult living donor liver transplantationS Hwang, C S Ahn, K H Kim, et al.
Neurosurgery|April 22, 2017
Male Gender Associated with Post-Treatment Seizure Risk of Pediatric Arteriovenous Malformation PatientsWuyang Yang, Erick M Westbroek, Heather Anderson-Keightly, et al.
British Journal of Cancer|June 27, 2007
A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future managementH-S Lee, S T Kim, J Lee, et al.
Chemical Biology & Drug Design|October 18, 2014
Synthesis and antitumor activity of natural compound aloe emodin derivativesNaraganahalli R Thimmegowda, Chanmi Park, Bettaswamigowda Shwetha, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradicationI J Choi, H C Jung, K W Choi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapyS Park, M-H Lee, M Seong, et al.
Pageof 122